| Q37057327 | Adult life after surviving lymphoma in childhood |
| Q69674842 | An analysis of prognostic factors in early stage Hodgkin's disease |
| Q34707420 | BEACOPP chemotherapy is a highly effective regimen in children and adolescents with high-risk Hodgkin lymphoma: a report from the Children's Oncology Group |
| Q33684739 | Benefits and risks of hormone replacement therapy in young adult cancer survivors with gonadal failure |
| Q34660950 | Bone mineral density deficits and fractures in survivors of childhood cancer |
| Q41733987 | Cancer and women |
| Q34491994 | Cancer, chemotherapy, and fertility |
| Q35560255 | Central causes of hypogonadism—functional and organic |
| Q59622002 | Chemotherapy for gestational trophoblastic tumours hastens menopause by 3 years |
| Q37732507 | Chemotherapy of Hodgkin's disease |
| Q37706528 | Current approaches to the management of pediatric Hodgkin lymphoma |
| Q39834906 | Current management of Hodgkin's disease |
| Q40162851 | Disorders of the endocrine system due to radiation and cytotoxic chemotherapy |
| Q34247887 | Drug-Induced Infertility |
| Q39521325 | Effects of cancer treatment on the reproductive system |
| Q40781737 | Effects of chemotherapy and irradiation on the gonads. |
| Q77397528 | Fertility and pregnancy after adjuvant chemotherapy for breast cancer |
| Q37195969 | Fertility in young men and women after treatment for lymphoma: a study of a population |
| Q34130106 | Fertility issues for cancer patients |
| Q37709972 | Fertility preservation after chemotherapy for Hodgkin lymphoma |
| Q35106163 | Fertility preservation and breast cancer: a review |
| Q35838156 | Fertility preservation in girls |
| Q36135438 | Fertility, reproductive outcomes, and health of offspring, of patients treated for Hodgkin's disease: an investigation including chromosome examinations |
| Q40109250 | Fetal Drug Exposure—Behavioral Teratogenesis |
| Q40147163 | Gonadal Injury Resulting From Chemotherapy |
| Q73093068 | Gonadal function after bone marrow transplantation for acute leukemia during childhood |
| Q34766583 | Gonadal function in Hodgkin's disease: long-term follow-up of chemotherapy |
| Q77371935 | Gonadal function in young patients successfully treated for Hodgkin disease |
| Q42525562 | Gonadal function of young adults after therapy of malignancies during childhood or adolescence |
| Q37200061 | Gynecologic complication of chronic graft-versus-host disease: Vaginal obstruction |
| Q36705967 | Hodgkin's disease in adults: the challenge |
| Q37019526 | Hormonal suppression for fertility preservation in males and females |
| Q58006522 | Hospital contacts for endocrine disorders in Adult Life after Childhood Cancer in Scandinavia (ALiCCS): a population-based cohort study |
| Q67880236 | Human granulosa-luteal cell response to vinblastine exposure in vitro |
| Q39635725 | Human mutagens: evidence from paternal exposure? |
| Q88639697 | Impact of ovarian transposition before pelvic irradiation on ovarian function among long-term survivors of childhood Hodgkin lymphoma: A report from the St. Jude Lifetime Cohort Study |
| Q45281364 | Induction of ovulation and pregnancy following lateral oophoropexy for Hodgkin's disease |
| Q73101467 | Influence of radiographic technique and equipment on absorbed ovarian dose associated with uterine artery embolization |
| Q34995996 | Late effects of childhood cancer therapy |
| Q39821025 | Late effects of treatment of cancer in children |
| Q68510643 | Lateral high abdominal ovariopexy: An original surgical technique for protection of the ovaries during curative radiotherapy for hodgkin's disease |
| Q34477813 | Long-Term Survival Among Patients With Hodgkin's Lymphoma Who Developed Breast Cancer: A Population-Based Study |
| Q33637106 | Long-term genetic and reproductive effects of ionizing radiation and chemotherapeutic agents on cancer patients and their offspring |
| Q72384418 | Long-term gonadal toxicity after therapy for Hodgkin's and non-Hodgkin's lymphoma |
| Q44665303 | Long-term outcome of treatment for Ann Arbor Stage I Hodgkin's disease: prognostic factors for survival and freedom from progression |
| Q73801777 | Long-term outcome of treatment for Ann Arbor stage 1 Hodgkin's disease: patterns of failure, late toxicity and second malignancies |
| Q41586639 | Long-term survivors of childhood cancer. The medical consequences of cure |
| Q70686517 | Lymphocyte predominant Hodgkin's disease: clinical presentation and results of treatment |
| Q73682171 | Malignant germ cell tumors of the ovary. Pregnancy considerations |
| Q40426169 | Mechanism and management of treatment-related gonadal failure in recipients of high dose chemoradiotherapy |
| Q70813740 | Mediastinal Hodgkin's disease. Significance of mediastinal involvement in early stage Hodgkin's disease |
| Q71727719 | Meiotic chromosomal changes and sterility produced by nitrogen mustard and procarbazine in mice |
| Q36655965 | Menses resumption after cancer treatment-induced amenorrhea occurs early or not at all |
| Q50948321 | Occupational Exposure to Antineoplastic Agents and Self-Reported Infertility Among Nurses and Pharmacists |
| Q36271067 | Oocyte donation treats infertility in survivors of malignancies: ten-year experience |
| Q37801015 | Options of Fertility Preservation in Female Cancer Patients |
| Q47574871 | Ovarian and Uterine Functions in Female Survivors of Childhood Cancers. |
| Q54265753 | Ovarian dysgerminoma: a retrospective analysis of results of treatment, sites of treatment failure, and radiosensitivity. |
| Q42502402 | Ovarian function after uterine artery embolization for leiomyomata: assessment with use of serum follicle stimulating hormone assay |
| Q35993603 | Patterns of survival in patients with advanced Hodgkin's disease (HD) treated in a single centre over 20 years |
| Q71868298 | Pelvic relapse following subtotal lymphoid irradiation in early stage Hodgkin's disease—An analysis of risk, management, and outcome |
| Q34489418 | Pregnancy after chemotherapy induced ovarian failure |
| Q34555063 | Pregnancy after cytotoxic chemotherapy for gestational trophoblastic tumours |
| Q42457000 | Preservation of ovarian function by ovarian transposition performed before pelvic irradiation during childhood |
| Q71218590 | Prolonged amenorrhea associated with total nodal irradiation for Hodgkin's disease |
| Q70280499 | Prospects for fertility after chemotherapy or radiation for neoplastic disease |
| Q34623393 | Protecting female fertility from cancer therapy. |
| Q70919518 | Reproductive Potential after Treatment for Hodgkin's Disease |
| Q41341055 | Reproductive and endocrine gonadal capacity in patients treated with COPP chemotherapy for Hodgkin's disease |
| Q74658340 | Reproductive sequelae of cancer treatment |
| Q33684727 | Reproductive technologies 1998: options available for the cancer patient |
| Q44510096 | Socio-medical situation for long-term survivors of Hodgkin's disease: a survey of 459 patients treated at one institution |
| Q40149015 | Staging laparotomy with splenectomy in children and adolescents with Hodgkin's disease |
| Q84624513 | Statement: cancer treatments and ovarian reserve |
| Q69822270 | The effect of cancer therapy on gonadal function |
| Q68974110 | The efficiency of different combined treatment programs (combination chemotherapy-radiotherapy) used for stage I-II Hodgkin's disease |
| Q34031463 | The long-term complications of chemotherapy in childhood genitourinary tumors |
| Q39600801 | The non-Hodgkin's lymphomas: pathology, staging, treatment |
| Q70362397 | The role of MOPP chemotherapy in early stage Hodgkin's disease |
| Q34121459 | Treating cancer patients. Practical monitoring and management of therapy-related complications. |
| Q73492818 | Uterine artery embolization: reduced radiation with refined technique |
| Q50921944 | [Radiation reactions in the gonads: importance in patient counseling]. |